B+
Bull case
25%
Probability
Target price
$110.00
Analysis reference price unavailable
Analysis 2026-09-30 · RankAlpha Sentiment Codex
MDT
MedtronicCNYSE / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Broad Q1 growth, raised FY2027 guidance and expanding ablation and surgical platforms support upside if growth persists after the extra week. The MiniMed separation could sharpen portfolio focus, subject to completion.
Posture
Mixed
Lead driver
Value
What changed
6 setup hits (3d) with net bullish as of 2026-10-24.
What can break
FY2026 non-GAAP operating margin declined 130 basis points, making margin conversion a continuing test. [#SEC-8K-2026-06-03]
Momentum
68
Value
57
Sentiment
48
Setup hits (3d)
6 · Net Bullish
AI TargetsBase $99.00 · Bull $110.00 · Bear $74.00Analysis 2026-09-30; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-30 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Bullish
Target $103.82
Why
Momentum68 · Δ7d +1.9
Value57 · Δ7d +0.3
Sentiment48 · Δ7d +0.3
So what
Balanced signals (Net Bullish). Wait for confirmation before sizing up.
Confirming evidence
- • 6 setup hits (3d) with net bullish as of 2026-10-24.
- • Value remains the lead driver in the composite, 7D delta +0.3.
Contradictions & invalidation
- • FY2026 non-GAAP operating margin declined 130 basis points, making margin conversion a continuing test. [#SEC-8K-2026-06-03]
- • Hugo's U.S. clearance remains limited to urologic procedures; broader indications and meaningful hospital utilization are not established by the September instrument clearance. Medtronic release
- • The approximately $570 million extra-week benefit complicates Q1 growth comparisons.
Catalyst clock
2026-10-09
MiniMed exchange-offer deadline
Lead driver: Value · See fundamentals
Momentum
68
8% active weight
Current posture
7d trendImproving
Δ7d
+1.9
Δ21d
+8.0
Value
57
47% active weight
Current posture
7d trendFlat
Δ7d
+0.3
Δ21d
-0.9
Sentiment
48
45% active weight
Current posture
7d trendSoftening
Δ7d
+0.3
Δ21d
-21.9
Why this grade
Composite grade C. Momentum 68.2 / Value 56.7 / Sentiment 48.1
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-30. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$99.00
Analysis reference price unavailable
Analysis 2026-09-30 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$74.00
Analysis reference price unavailable
Analysis 2026-09-30 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$122.05B
Beta
0.72
Shares Out
1.28B
P/E (TTM)
26.3
P/S (TTM)
3.59
P/FCF (TTM)
78.40
Rev YoY
+9.9%
EPS YoY
+17.6%
Gross Margin
+60.3%
Op Margin
+19.3%
Net Debt
$19.93B
Current Ratio
2.13
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data